These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34883448)

  • 21. Generation of isogenic and homozygous MEN1 mutant cell lines from patient-derived iPSCs using CRISPR/Cas9.
    Even-Zohar N; Metin-Armagan D; Ben-Shlomo A; Sareen D; Melmed S
    Stem Cell Res; 2023 Jun; 69():103124. PubMed ID: 37209468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of induced pluripotent stem cell line (UCSFi001-A-77) carrying a biallelic frameshift variant in exon 4 of SGIP1 through CRISPR/Cas9.
    Fatima N; Dillen L; Hommersom MP; Çepni E; Fatima F; van Beusekom E; Albert S; Ali Khan A; de Brouwer APM; van Bokhoven H
    Stem Cell Res; 2024 Oct; 80():103511. PubMed ID: 39098170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
    Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
    Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9.
    Gargano C; Vartanian-Grimaldi JS; Hovhannisyan Y; Joanne P; Agbulut O; Li Z; Parlakian A; Decaux JF
    Stem Cell Res; 2023 Dec; 73():103254. PubMed ID: 38035530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes.
    Yasutake H; Lee JK; Hashimoto A; Masuyama K; Li J; Kuramoto Y; Higo S; Hikoso S; Hidaka K; Naito AT; Miyagawa S; Sawa Y; Komuro I; Sakata Y
    Sci Rep; 2021 May; 11(1):10351. PubMed ID: 33990626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of two CRISPR/Cas edited human induced pluripotent stem cell lines (DHMi005-A-3 and DHMi005-A-4) carrying a FLAG-tag after exon 9 of the TBX5 gene.
    Lahm H; Stieglbauer S; Neb I; Doppler SA; Schneider S; Dzilic E; Lange R; Krane M; Dreßen M
    Stem Cell Res; 2023 Feb; 66():103011. PubMed ID: 36610218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of a heterozygous SCN5A knockout human induced pluripotent stem cell line by CRISPR/Cas9 edition.
    Gizon M; Duboscq-Bidot L; El Kassar L; Bobin P; Ader F; Giraud-Triboult K; Charron P; Villard E; Fontaine V; Neyroud N
    Stem Cell Res; 2022 Apr; 60():102680. PubMed ID: 35093717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of gene corrected human isogenic iPSC lines (IDVi003-A_CR13, IDVi003-A_CR21, IDVi003-A_CR24) from an inherited retinal dystrophy patient-derived IPSC line ITM2B-5286-3 (IDVi003-A) carrying the ITM2B c.782A > C variant using CRISPR/Cas9.
    Ben Yacoub T; Letellier C; Wohlschlegel J; Condroyer C; Slembrouck-Brec A; Goureau O; Zeitz C; Audo I
    Stem Cell Res; 2023 Sep; 71():103166. PubMed ID: 37473460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).
    Janz A; Zink M; Cirnu A; Hartleb A; Albrecht C; Rost S; Klopocki E; Günther K; Edenhofer F; Ergün S; Gerull B
    Stem Cell Res; 2021 May; 53():102256. PubMed ID: 33640690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of three CRISPR/Cas9 edited human induced pluripotent stem cell lines (DHMi005-A-5, DHMi005-A-6 and DHMi005-A-7) carrying a Holt-Oram Syndrome patient-specific TBX5 mutation with known cardiac phenotype and a FLAG-tag after exon 9 of the TBX5 gene.
    Lahm H; Stieglbauer S; Neb I; Doppler S; Schneider S; Dzilic E; Lange R; Krane M; Dreßen M
    Stem Cell Res; 2023 Jun; 69():103123. PubMed ID: 37210946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Filamin C in cardiomyopathy: from physiological roles to DNA variants.
    Song S; Shi A; Lian H; Hu S; Nie Y
    Heart Fail Rev; 2022 Jul; 27(4):1373-1385. PubMed ID: 34535832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The assembly and evaluation of antisense oligonucleotides applied in exon skipping for titin-based mutations in dilated cardiomyopathy.
    Hahn JK; Neupane B; Pradhan K; Zhou Q; Testa L; Pelzl L; Maleck C; Gawaz M; Gramlich M
    J Mol Cell Cardiol; 2019 Jun; 131():12-19. PubMed ID: 30998980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and characterization of a human iPSC line and gene-corrected isogenic line derived from a patient with a CELF2 gene mutation.
    Hua M; Williams L; Burns K; Liu S; Ellis J; Innes AM; McPherson M; Yang G
    Stem Cell Res; 2024 Apr; 76():103344. PubMed ID: 38364506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of a CRISPR/Cas edited human induced pluripotent stem cell line DHMi005-A-1 carrying a patient-specific disease-causing point mutation in the TBX5 gene.
    Lahm H; Heinrich P; Zierler E; Dzilic E; Neb I; Luzius T; Doppler SA; Schneider S; Lange R; Krane M; Dreßen M
    Stem Cell Res; 2022 Apr; 60():102691. PubMed ID: 35121196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.
    Agrawal T; Maddileti S; Mariappan I
    Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
    Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ
    J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing.
    Tidball AM; Dang LT; Glenn TW; Kilbane EG; Klarr DJ; Margolis JL; Uhler MD; Parent JM
    Stem Cell Reports; 2017 Sep; 9(3):725-731. PubMed ID: 28781079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients.
    Caudal A; Mondejar-Parreño G; Vera CD; Williams DR; Shenoy SP; Liang D; Wu JC
    Stem Cell Res; 2022 Aug; 63():102855. PubMed ID: 35853412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcellular Remodeling in Filamin C Deficient Mouse Hearts Impairs Myocyte Tension Development during Progression of Dilated Cardiomyopathy.
    Powers JD; Kirkland NJ; Liu C; Razu SS; Fang X; Engler AJ; Chen J; McCulloch AD
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.